"Mycophenolic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION.
Descriptor ID |
D009173
|
MeSH Number(s) |
D02.241.081.193.678 D10.251.618
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycophenolic Acid".
Below are MeSH descriptors whose meaning is more specific than "Mycophenolic Acid".
This graph shows the total number of publications written about "Mycophenolic Acid" by people in this website by year, and whether "Mycophenolic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2000 | 2 | 1 | 3 |
2003 | 1 | 0 | 1 |
2004 | 3 | 0 | 3 |
2005 | 2 | 0 | 2 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 1 | 2 | 3 |
2009 | 2 | 3 | 5 |
2010 | 1 | 4 | 5 |
2011 | 1 | 2 | 3 |
2012 | 1 | 1 | 2 |
2014 | 1 | 5 | 6 |
2015 | 0 | 1 | 1 |
2016 | 3 | 6 | 9 |
2017 | 7 | 2 | 9 |
2018 | 3 | 4 | 7 |
2019 | 1 | 2 | 3 |
2020 | 1 | 0 | 1 |
2022 | 1 | 1 | 2 |
2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycophenolic Acid" by people in Profiles.
-
Panniculitis with late onset enthesitis-related arthritis: a case report. Pediatr Rheumatol Online J. 2023 Sep 11; 21(1):97.
-
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. N Engl J Med. 2023 Jun 22; 388(25):2338-2348.
-
International cohort of 382 children with lupus nephritis - presentation, treatment and outcome at 24?months. Pediatr Nephrol. 2023 11; 38(11):3699-3709.
-
Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors? Transplant Cell Ther. 2022 08; 28(8):500.e1-500.e10.
-
Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review. Pediatr Rheumatol Online J. 2022 Feb 22; 20(1):16.
-
Severe adult-onset atopic dermatitis mistaken for cutaneous T-cell lymphoma in a medically complex patient. BMJ Case Rep. 2020 Mar 10; 13(3).
-
Lupus nephritis. Nat Rev Dis Primers. 2020 01 23; 6(1):7.
-
Mycophenolate mofetil as an alternative treatment in sarcoidosis. Pulm Pharmacol Ther. 2019 10; 58:101840.
-
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning. Blood Adv. 2019 06 25; 3(12):1858-1867.
-
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 09; 25(9):1744-1755.